🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amy Cross

GlaxoSmithKline (United Kingdom)

ORCID: 0000-0002-2592-6251

Also affiliated with Age UK, University of Oxford

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection”.

Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection

Cell Reports(2022)10.1016/j.celrep.2022.111478

N/A

0DataRank · unranked

44 citations

Marcos Iglesias, Jakub Tomala, Arabella Young, Jennifer Smith, Joseph A. Perry +20 more

Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.29.493918

N/A

0DataRank · unranked

1 citations

Marcos Iglesias, Jakub Tomala, Arabella Young, Jennifer Smith, Joseph A. Perry +20 more

Decoding mTOR signalling heterogeneity in the tumour microenvironment using multiplexed imaging and graph convolutional networks

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.30.573693

N/A

0DataRank · unranked

1 citations

Mark Eastwood, Megan M. Jones, Amy Cross, Joanna Hester, Fadi Issa +3 more